(Q40307026)

19 September 2017

Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors (English)

1 reference

19 September 2017

Mio Nukiwa

1

1 reference

19 September 2017

Sita Andarini

2

1 reference

19 September 2017

Jamal Zaini

3

1 reference

19 September 2017

Hong Xin

4

1 reference

19 September 2017

Masahiko Kanehira

5

1 reference

19 September 2017

Takuji Suzuki

6

1 reference

19 September 2017

Tatsuro Fukuhara

7

1 reference

19 September 2017

Hiroyuki Mizuguchi

8

1 reference

19 September 2017

Takao Hayakawa

9

1 reference

19 September 2017

Yasuo Saijo

10

1 reference

19 September 2017

Toshihiro Nukiwa

11

1 reference

19 September 2017

Toshiaki Kikuchi

12

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

European Journal of Immunology

19 September 2017

1 reference

19 September 2017

36

1 reference

19 September 2017

4

1 reference

19 September 2017

1019-1027

1 reference

Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination

19 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Chemokines and dendritic cells: a crucial alliance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

A new class of membrane-bound chemokine with a CX3C motif

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

An overview of cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

CD40/CD154 interactions at the interface of tolerance and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Chemokines as regulators of T cell differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Chemokines and cell migration in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

The role of chemokines in linking innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Genetically modified dendritic cells for therapeutic immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Chemokines: agents for the immunotherapy of cancer?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Gene modification strategies to induce tumor immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Intratumoral expression of macrophage-derived chemokine induces CD4+ T cell-independent antitumor immunity in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535549

7 January 2021

Identifiers

DOI

10.1002/EJI.200535549

1 reference

19 September 2017

1 reference